{"gene":"SCYL1","run_date":"2026-04-28T20:42:07","timeline":{"discoveries":[{"year":2007,"finding":"Loss-of-function mutation in Scyl1, encoding an evolutionarily conserved N-terminal kinase-like (pseudokinase) protein, was identified as the cause of the autosomal recessive murine neurodegenerative disease 'muscle deficient' (mdf), characterized by cerebellar atrophy, Purkinje cell loss, and optic nerve atrophy. Scyl1 was found to be prominently expressed in neurons and enriched at CNS synapses and neuromuscular junctions.","method":"Positional cloning and loss-of-function mutation mapping in mdf mice; immunohistochemistry and expression analysis","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 — direct genetic identification of causative mutation with histopathological phenotypic readout, replicated across independent analyses","pmids":["17571074"],"is_preprint":false},{"year":2008,"finding":"SCYL1 (Scy1-like 1) was identified as a binding partner of COPI coat components (coatomer). SCYL1 uses a C-terminal RKLD-COO⁻ sequence (analogous to the KKXX-COO⁻ motif of transmembrane ER-resident proteins) to bind COPI coats. SCYL1 co-localizes with βCOP at the ER-Golgi intermediate compartment (ERGIC) and cis-Golgi in an Arf1-independent manner, and siRNA-mediated knockdown of SCYL1 disrupts COPI-mediated retrograde trafficking of the KDEL receptor to the ER without affecting anterograde traffic.","method":"Mass spectrometry-based binding partner screen, pull-down assays, co-immunoprecipitation from brain lysates, siRNA knockdown with KDEL receptor trafficking assay, immunofluorescence co-localization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (MS screen, co-IP, siRNA functional assay) in a single study establishing COPI interaction and functional role","pmids":["18556652"],"is_preprint":false},{"year":2010,"finding":"SCYL1 knockdown causes an increase in Golgi surface area and volume and disorganization of Golgi ultrastructure (increased cisternal luminal width), without disrupting Golgi polarity or cisternal number. SCYL1 localizes to the Golgi in a manner dependent on the golgin p115 network, and SCYL1 interacts with the cis-Golgi-associated protein 58K/FTCD (formiminotransferase cyclodeaminase), placing SCYL1 at the interface of the golgin network and COPI trafficking.","method":"siRNA knockdown with 3D confocal imaging and electron microscopy of Golgi morphology; co-immunoprecipitation of SCYL1 with 58K/FTCD; immunofluorescence after p115 knockdown","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2–3 — functional knockdown phenotype with EM and co-IP validation, single lab study","pmids":["20209057"],"is_preprint":false},{"year":2010,"finding":"SCYL1 functions as a cytoplasmic component of the mammalian nuclear tRNA export machinery. SCYL1 binds tRNA saturably, associates with the nuclear pore complex via interaction with Nup98, and co-purifies with exportin-t, exportin-5, RanGTPase, and eEF-1A. SCYL1 interacts directly with exportin-t and RanGTP (but not RanGDP) in vitro, and exportin-t/tRNA/SCYL1/RanGTP form a quaternary complex in vitro. Overexpression of SCYL1 rescues export of a nuclear export-defective tRNA mutant in COS-7 cells.","method":"In vitro tRNA binding assay, co-purification/co-immunoprecipitation with nuclear pore and export machinery components, in vitro reconstitution of quaternary complex, functional rescue assay in COS-7 cells","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro reconstitution plus cellular functional assay, single lab study","pmids":["20505071"],"is_preprint":false},{"year":2012,"finding":"Neural-specific deletion of Scyl1 is sufficient to cause progressive lower motor neuron (LMN) degeneration and motor dysfunction in mice, demonstrating that SCYL1 acts in a cell-autonomous manner in neurons. Loss of Scyl1 results in mislocalization and accumulation of TDP-43 and ubiquilin 2 into cytoplasmic inclusions within LMNs—a pathological hallmark of ALS. Skeletal muscle-specific deletion does not cause motor dysfunction, confirming the neural cell-autonomous requirement.","method":"Conditional (neural-specific and muscle-specific) Scyl1 knockout mice; immunofluorescence and immunohistochemistry for TDP-43 and ubiquilin 2 localization; neuropathological analysis of motor neurons and peripheral nerves","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific conditional knockouts with defined molecular (TDP-43 mislocalization) and cellular (LMN degeneration) phenotypic readouts","pmids":["23175812"],"is_preprint":false},{"year":2014,"finding":"SCYL1 oligomerizes through centrally located HEAT repeats and uses its C-terminal RKXX-COO⁻ motif to interact directly with the appendage domain of coatomer subunit γ-2 (γ2-COP/COPG2). Through a distinct binding site, SCYL1 selectively interacts with class II Arfs (notably Arf4), thereby functioning as a scaffold that links class II Arfs specifically to γ2-COP-containing COPI subcomplexes. Disruption of this scaffolding causes tubulation of the ERGIC and cis-Golgi, similar to loss of Arf or Arf-GEF function.","method":"Pull-down assays mapping direct interaction with γ2-COP appendage domain; identification of Arf4-selective binding; dominant-negative and knockdown approaches with Golgi morphology readout (confocal and electron microscopy)","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1–2 — direct binding mapped to specific domains, orthogonal genetic and cell biological validation, mechanistic specificity established for Arf class and COP subcomplex","pmids":["24481816"],"is_preprint":false}],"current_model":"SCYL1 is a catalytically inactive pseudokinase that functions as an accessory scaffold in COPI-mediated retrograde membrane trafficking by binding COPI coats via its C-terminal RKXX-COO⁻ motif and linking class II Arfs (Arf4) to γ2-COP-containing COPI subcomplexes through its HEAT repeat oligomerization domain; it also participates in nuclear tRNA export by forming a complex with exportin-t and RanGTP at the nuclear pore, and its loss in neurons causes TDP-43 mislocalization, lower motor neuron degeneration, and cerebellar atrophy."},"narrative":{"teleology":[{"year":2007,"claim":"Positional cloning of the murine mdf locus identified Scyl1 as a neuronally-expressed pseudokinase whose loss causes cerebellar atrophy and Purkinje cell degeneration, establishing it as essential for neuronal survival but leaving its molecular function unknown.","evidence":"Positional cloning and loss-of-function mutation mapping in mdf mice with immunohistochemistry","pmids":["17571074"],"confidence":"High","gaps":["Molecular mechanism by which SCYL1 supports neuronal viability was unknown","Whether SCYL1 functions cell-autonomously in neurons was untested","No binding partners or pathway placement identified"]},{"year":2008,"claim":"Discovery that SCYL1 directly binds COPI coat components via a C-terminal RKLD-COO⁻ motif and is required for retrograde KDEL receptor trafficking placed this pseudokinase in the COPI-dependent ER-Golgi recycling pathway.","evidence":"Mass spectrometry screen, co-IP from brain lysates, siRNA knockdown with KDEL receptor trafficking assay","pmids":["18556652"],"confidence":"High","gaps":["Which specific COPI subunit(s) SCYL1 engages was not resolved","Whether SCYL1 links COPI to specific Arf GTPases was unknown","Connection between COPI trafficking role and neurodegeneration not established"]},{"year":2010,"claim":"Two parallel studies expanded SCYL1's functional repertoire: one showed SCYL1 depletion disrupts Golgi architecture and placed it at the golgin p115/58K network interface, while another demonstrated SCYL1 forms a quaternary complex with exportin-t, tRNA, and RanGTP, implicating it in nuclear tRNA export.","evidence":"siRNA knockdown with 3D confocal and EM for Golgi morphology; in vitro reconstitution of exportin-t/tRNA/SCYL1/RanGTP complex and tRNA export rescue in COS-7 cells","pmids":["20209057","20505071"],"confidence":"Medium","gaps":["Relative physiological importance of tRNA export versus COPI trafficking roles not resolved","Whether tRNA export function is relevant to the neurodegenerative phenotype is unknown","Golgi morphology study from a single lab without independent replication"]},{"year":2012,"claim":"Neural-specific conditional knockout demonstrated SCYL1 acts cell-autonomously in neurons, and linked its loss to cytoplasmic TDP-43 and ubiquilin 2 accumulation in lower motor neurons — hallmarks of ALS pathology — bridging the trafficking role to a neurodegeneration-relevant mechanism.","evidence":"Conditional neural-specific and muscle-specific Scyl1 knockout mice with TDP-43 and ubiquilin 2 immunolocalization","pmids":["23175812"],"confidence":"High","gaps":["Causal chain from COPI trafficking defect to TDP-43 mislocalization not delineated","Whether SCYL1 loss causes TDP-43 aggregation through impaired autophagy, proteasome dysfunction, or another route is unresolved","No human genetic disease association demonstrated"]},{"year":2014,"claim":"Biochemical mapping revealed SCYL1 oligomerizes through HEAT repeats and acts as a selective scaffold linking class II Arfs (Arf4) to γ2-COP-containing COPI subcomplexes via distinct binding sites, providing a structural explanation for its specificity in retrograde trafficking.","evidence":"Pull-down assays mapping γ2-COP appendage domain interaction; Arf4-selective binding; dominant-negative and knockdown with Golgi morphology readout","pmids":["24481816"],"confidence":"High","gaps":["No high-resolution structural model of the SCYL1–γ2-COP–Arf4 ternary complex","Whether additional cargo adaptors cooperate with SCYL1 at the ERGIC is unknown","Functional significance of SCYL1 pseudokinase domain remains uncharacterized"]},{"year":null,"claim":"The mechanistic link between SCYL1's COPI scaffolding and/or tRNA export roles and the downstream TDP-43 mislocalization causing motor neuron degeneration remains unresolved, as does the functional significance of the catalytically inactive kinase-like domain.","evidence":"","pmids":[],"confidence":"High","gaps":["No causal pathway connecting COPI trafficking or tRNA export defects to TDP-43 proteinopathy","Pseudokinase domain function or potential non-canonical catalytic activity not addressed","Human genetic validation as a Mendelian disease gene for neurodegeneration not reported in this timeline"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[1,5]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[3]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[1,2,5]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1,5]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[1,2,5]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[1,5]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[3]}],"complexes":["COPI coat complex (accessory/scaffold)","exportin-t/RanGTP tRNA export complex"],"partners":["COPG2","ARF4","XPOT","RAN","FTCD","NUP98"],"other_free_text":[]},"mechanistic_narrative":"SCYL1 is a catalytically inactive pseudokinase that functions as a scaffolding adaptor in COPI-mediated retrograde membrane trafficking and in nuclear tRNA export. It oligomerizes via central HEAT repeats and uses a C-terminal RKXX-COO⁻ motif to bind the γ2-COP appendage domain, selectively linking class II Arfs (Arf4) to γ2-COP-containing COPI subcomplexes at the ERGIC and cis-Golgi; its loss disrupts COPI-dependent KDEL receptor recycling and causes Golgi disorganization [PMID:18556652, PMID:24481816, PMID:20209057]. SCYL1 also participates in nuclear tRNA export by forming a quaternary complex with exportin-t, tRNA, and RanGTP at the nuclear pore [PMID:20505071]. Neural-specific loss of Scyl1 in mice causes progressive lower motor neuron degeneration with cytoplasmic TDP-43 and ubiquilin 2 accumulation, cerebellar Purkinje cell loss, and optic nerve atrophy, establishing a cell-autonomous neuronal requirement [PMID:17571074, PMID:23175812]."},"prefetch_data":{"uniprot":{"accession":"Q96KG9","full_name":"N-terminal kinase-like protein","aliases":["Coated vesicle-associated kinase of 90 kDa","SCY1-like protein 1","Telomerase regulation-associated protein","Telomerase transcriptional element-interacting factor","Teratoma-associated tyrosine kinase"],"length_aa":808,"mass_kda":89.6,"function":"Regulates COPI-mediated retrograde protein traffic at the interface between the Golgi apparatus and the endoplasmic reticulum (PubMed:18556652). Involved in the maintenance of the Golgi apparatus morphology (PubMed:26581903) Acts as a transcriptional activator. It binds to three different types of GC-rich DNA binding sites (box-A, -B and -C) in the beta-polymerase promoter region. It also binds to the TERT promoter region","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q96KG9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/SCYL1","classification":"Common Essential","n_dependent_lines":364,"n_total_lines":1208,"dependency_fraction":0.30132450331125826},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000142186","cell_line_id":"CID001269","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleoplasm","grade":2},{"compartment":"golgi","grade":1}],"interactors":[{"gene":"COPA","stoichiometry":4.0},{"gene":"COPB2","stoichiometry":4.0},{"gene":"COPE","stoichiometry":4.0},{"gene":"CAPZB","stoichiometry":0.2},{"gene":"COPG1","stoichiometry":0.2},{"gene":"COPZ1","stoichiometry":0.2},{"gene":"ATP6V1E1","stoichiometry":0.2},{"gene":"SEC24C","stoichiometry":0.2},{"gene":"COPB1","stoichiometry":0.2},{"gene":"TMED10","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001269","total_profiled":1310},"omim":[{"mim_id":"616719","title":"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21; SCAR21","url":"https://www.omim.org/entry/616719"},{"mim_id":"607983","title":"GOLGIN, RAB6-INTERACTING; GORAB","url":"https://www.omim.org/entry/607983"},{"mim_id":"607982","title":"SCY1-LIKE 1; SCYL1","url":"https://www.omim.org/entry/607982"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SCYL1"},"hgnc":{"alias_symbol":["HT019","P105","GKLP","NKTL","TAPK","TRAP","TEIF","MGC78454"],"prev_symbol":["NTKL"]},"alphafold":{"accession":"Q96KG9","domains":[{"cath_id":"3.30.200.20","chopping":"15-97","consensus_level":"medium","plddt":90.6582,"start":15,"end":97},{"cath_id":"1.10.510.10","chopping":"99-272","consensus_level":"medium","plddt":92.8667,"start":99,"end":272},{"cath_id":"1.25.10.10","chopping":"463-556_570-586","consensus_level":"medium","plddt":88.8639,"start":463,"end":586}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96KG9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96KG9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96KG9-F1-predicted_aligned_error_v6.png","plddt_mean":75.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SCYL1","jax_strain_url":"https://www.jax.org/strain/search?query=SCYL1"},"sequence":{"accession":"Q96KG9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96KG9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96KG9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96KG9"}},"corpus_meta":[{"pmid":"1956402","id":"PMC_1956402","title":"Generation of p50 subunit of NF-kappa B by processing of p105 through an ATP-dependent pathway.","date":"1991","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/1956402","citation_count":294,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1531086","id":"PMC_1531086","title":"A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site.","date":"1992","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1531086","citation_count":283,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2159546","id":"PMC_2159546","title":"Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters.","date":"1990","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/2159546","citation_count":254,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1532257","id":"PMC_1532257","title":"The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.","date":"1992","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1532257","citation_count":238,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7636984","id":"PMC_7636984","title":"Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters.","date":"1995","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/7636984","citation_count":221,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8255759","id":"PMC_8255759","title":"Proteolytic degradation of MAD3 (I kappa B alpha) and enhanced processing of the NF-kappa B precursor p105 are obligatory steps in the activation of NF-kappa B.","date":"1993","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/8255759","citation_count":187,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9950430","id":"PMC_9950430","title":"TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/9950430","citation_count":184,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9256285","id":"PMC_9256285","title":"The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas.","date":"1997","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9256285","citation_count":179,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1639070","id":"PMC_1639070","title":"The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50.","date":"1992","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/1639070","citation_count":178,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10469655","id":"PMC_10469655","title":"NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10469655","citation_count":174,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8628291","id":"PMC_8628291","title":"A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8628291","citation_count":166,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19531803","id":"PMC_19531803","title":"Suppression of LPS-induced TNF-alpha production in macrophages by cAMP is mediated by PKA-AKAP95-p105.","date":"2009","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/19531803","citation_count":161,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10835356","id":"PMC_10835356","title":"SCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinase.","date":"2000","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10835356","citation_count":156,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1501885","id":"PMC_1501885","title":"Transcriptional activator Tax of HTLV-1 binds to the NF-kappa B precursor p105.","date":"1992","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/1501885","citation_count":150,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8428580","id":"PMC_8428580","title":"The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B.","date":"1993","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8428580","citation_count":148,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12871932","id":"PMC_12871932","title":"Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105 stability.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12871932","citation_count":139,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17124531","id":"PMC_17124531","title":"Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis.","date":"2006","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/17124531","citation_count":133,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9151857","id":"PMC_9151857","title":"Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters.","date":"1997","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/9151857","citation_count":133,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19524538","id":"PMC_19524538","title":"The Nfkb1 and Nfkb2 proteins p105 and p100 function as the core of high-molecular-weight heterogeneous complexes.","date":"2009","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/19524538","citation_count":130,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8692272","id":"PMC_8692272","title":"Effects on NF-kappa B1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8692272","citation_count":129,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1645591","id":"PMC_1645591","title":"Functional analysis of E2-mediated repression of the HPV18 P105 promoter.","date":"1991","source":"The New biologist","url":"https://pubmed.ncbi.nlm.nih.gov/1645591","citation_count":129,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9529315","id":"PMC_9529315","title":"Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappaB1) but expressing p50.","date":"1998","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9529315","citation_count":117,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12482991","id":"PMC_12482991","title":"betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12482991","citation_count":116,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11297557","id":"PMC_11297557","title":"Direct phosphorylation of NF-kappaB1 p105 by the IkappaB kinase complex on serine 927 is essential for signal-induced p105 proteolysis.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11297557","citation_count":112,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12832462","id":"PMC_12832462","title":"NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12832462","citation_count":107,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1388725","id":"PMC_1388725","title":"Molecular cloning and characterization of a novel Rel/NF-kappa B family member displaying structural and functional homology to NF-kappa B p50/p105.","date":"1992","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/1388725","citation_count":103,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8454856","id":"PMC_8454856","title":"Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.","date":"1993","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8454856","citation_count":97,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23319859","id":"PMC_23319859","title":"Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation.","date":"2013","source":"International journal of nanomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/23319859","citation_count":97,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9218802","id":"PMC_9218802","title":"Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation.","date":"1997","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9218802","citation_count":97,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10207090","id":"PMC_10207090","title":"Structural motifs involved in ubiquitin-mediated processing of the NF-kappaB precursor p105: roles of the glycine-rich region and a downstream ubiquitination domain.","date":"1999","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10207090","citation_count":97,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25860612","id":"PMC_25860612","title":"KPC1-mediated ubiquitination and proteasomal processing of NF-κB1 p105 to p50 restricts tumor growth.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25860612","citation_count":93,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8334994","id":"PMC_8334994","title":"Common structural constituents confer I kappa B activity to NF-kappa B p105 and I kappa B/MAD-3.","date":"1993","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8334994","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10970863","id":"PMC_10970863","title":"Cotranslational dimerization of the Rel homology domain of NF-kappaB1 generates p50-p105 heterodimers and is required for effective p50 production.","date":"2000","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10970863","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7966593","id":"PMC_7966593","title":"Tax induces nuclear translocation of NF-kappa B through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of I kappa B alpha/MAD3.","date":"1994","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/7966593","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3549742","id":"PMC_3549742","title":"Modulation of the nuclear antigen p105 as a function of cell-cycle progression.","date":"1987","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/3549742","citation_count":82,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18556652","id":"PMC_18556652","title":"Scyl1, mutated in a recessive form of spinocerebellar neurodegeneration, regulates COPI-mediated retrograde traffic.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18556652","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9430676","id":"PMC_9430676","title":"NF-kappa B p105 processing via the ubiquitin-proteasome pathway.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9430676","citation_count":77,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15519191","id":"PMC_15519191","title":"Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase.","date":"2004","source":"European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/15519191","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8626394","id":"PMC_8626394","title":"Phosphorylation of p105 PEST sequence via a redox-insensitive pathway up-regulates processing of p50 NF-kappaB.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8626394","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1533881","id":"PMC_1533881","title":"p105, the NF-kappa B p50 precursor protein, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.","date":"1992","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/1533881","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20713524","id":"PMC_20713524","title":"miR-335 directly targets Rb1 (pRb/p105) in a proximal connection to p53-dependent stress response.","date":"2010","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/20713524","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9247567","id":"PMC_9247567","title":"Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells.","date":"1997","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9247567","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11953428","id":"PMC_11953428","title":"The NEDD8 pathway is essential for SCF(beta -TrCP)-mediated ubiquitination and processing of the NF-kappa B precursor p105.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11953428","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8414497","id":"PMC_8414497","title":"HTLV-I encoded Tax in association with NF-kappa B precursor p105 enhances nuclear localization of NF-kappa B p50 and p65 in transfected cells.","date":"1993","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8414497","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19060899","id":"PMC_19060899","title":"Proteolysis of NF-kappaB1 p105 is essential for T cell antigen receptor-induced proliferation.","date":"2008","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19060899","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9535861","id":"PMC_9535861","title":"Enzymes catalyzing ubiquitination and proteolytic processing of the p105 precursor of nuclear factor kappaB1.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9535861","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17571074","id":"PMC_17571074","title":"Mutation in the Scyl1 gene encoding amino-terminal kinase-like protein causes a recessive form of spinocerebellar neurodegeneration.","date":"2007","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/17571074","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15699325","id":"PMC_15699325","title":"Phosphorylation at Thr-290 regulates Tpl2 binding to NF-kappaB1/p105 and Tpl2 activation and degradation by lipopolysaccharide.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15699325","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22733995","id":"PMC_22733995","title":"Coordinate regulation of TPL-2 and NF-κB signaling in macrophages by NF-κB1 p105.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22733995","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7853483","id":"PMC_7853483","title":"Regulation of I kappa B alpha and p105 in monocytes and macrophages persistently infected with human immunodeficiency virus.","date":"1995","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/7853483","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14673179","id":"PMC_14673179","title":"Dual effects of IkappaB kinase beta-mediated phosphorylation on p105 Fate: SCF(beta-TrCP)-dependent degradation and SCF(beta-TrCP)-independent processing.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14673179","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11295495","id":"PMC_11295495","title":"Mechanisms of ubiquitin-mediated, limited processing of the NF-kappaB1 precursor protein p105.","date":"2001","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/11295495","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20209057","id":"PMC_20209057","title":"Scyl1 regulates Golgi morphology.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20209057","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15611242","id":"PMC_15611242","title":"BCL-6 negatively regulates expression of the NF-kappaB1 p105/p50 subunit.","date":"2005","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15611242","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11112416","id":"PMC_11112416","title":"17 beta-estradiol inhibits tumor necrosis factor-alpha-induced nuclear factor-kappa B activation by increasing nuclear factor-kappa B p105 level in MCF-7 breast cancer cells.","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11112416","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2214017","id":"PMC_2214017","title":"Binding of p53 and p105-RB is not sufficient for oncogenic transformation by a hybrid polyomavirus-simian virus 40 large T antigen.","date":"1990","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/2214017","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15629778","id":"PMC_15629778","title":"High levels of p105 (NFKB1) and p100 (NFKB2) proteins in HPV16-transformed keratinocytes: role of E6 and E7 oncoproteins.","date":"2005","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/15629778","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9624136","id":"PMC_9624136","title":"Ceramide activates NFkappaB by inducing the processing of p105.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9624136","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1437141","id":"PMC_1437141","title":"Identification of complex formation between two intracellular tyrosine kinase substrates: human c-Rel and the p105 precursor of p50 NF-kappa B.","date":"1992","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/1437141","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1979714","id":"PMC_1979714","title":"Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics.","date":"1990","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/1979714","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21954853","id":"PMC_21954853","title":"Omega-3 docosahexaenoic acid and procyanidins inhibit cyclo-oxygenase activity and attenuate NF-κB activation through a p105/p50 regulatory mechanism in macrophage inflammation.","date":"2012","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/21954853","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1427874","id":"PMC_1427874","title":"Chromosomal localization of the genes encoding the p50/p105 subunits of NF-kappa B (NFKB2) and the I kappa B/MAD-3 (NFKBI) inhibitor of NF-kappa B to 4q24 and 14q13, respectively.","date":"1992","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1427874","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7729425","id":"PMC_7729425","title":"Downregulation of MHC class I expression due to interference with p105-NF kappa B1 processing by Ad12E1A.","date":"1995","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/7729425","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19234210","id":"PMC_19234210","title":"NF-kappa B1 p105 regulates T cell homeostasis and prevents chronic inflammation.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19234210","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27932881","id":"PMC_27932881","title":"Preparation and antitumor evaluation of self-assembling oleanolic acid-loaded Pluronic P105/d-α-tocopheryl polyethylene glycol succinate mixed micelles for non-small-cell lung cancer treatment.","date":"2016","source":"International journal of nanomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/27932881","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3048631","id":"PMC_3048631","title":"Flow cytometric analysis of pituitary tumors. Correlation of nuclear antigen p105 and DNA content with clinical behavior.","date":"1988","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/3048631","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8183915","id":"PMC_8183915","title":"Alternative splicing of RNA transcripts encoded by the murine p105 NF-kappa B gene generates I kappa B gamma isoforms with different inhibitory activities.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8183915","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23646894","id":"PMC_23646894","title":"O-GlcNAcylation and p50/p105 binding of c-Rel are dynamically regulated by LPS and glucosamine in BV2 microglia cells.","date":"2013","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23646894","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24806516","id":"PMC_24806516","title":"Glucose transporter and folic acid receptor-mediated Pluronic P105 polymeric micelles loaded with doxorubicin for brain tumor treating.","date":"2014","source":"Journal of drug targeting","url":"https://pubmed.ncbi.nlm.nih.gov/24806516","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24481816","id":"PMC_24481816","title":"Scyl1 scaffolds class II Arfs to specific subcomplexes of coatomer through the γ-COP appendage domain.","date":"2014","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/24481816","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7684738","id":"PMC_7684738","title":"Skin-specific expression of a truncated E1a oncoprotein binding to p105-Rb leads to abnormal hair follicle maturation without increased epidermal proliferation.","date":"1993","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7684738","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20001340","id":"PMC_20001340","title":"NF-kappaB signalling proteins p50/p105, p52/p100, RelA, and IKKepsilon are over-expressed in oesophageal squamous cell carcinomas.","date":"2009","source":"Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/20001340","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11976329","id":"PMC_11976329","title":"The death domain of NF-kappa B1 p105 is essential for signal-induced p105 proteolysis.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11976329","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23661994","id":"PMC_23661994","title":"Dietary phytochemicals as potent chemotherapeutic agents against breast cancer: Inhibition of NF-κB pathway via molecular interactions in rel homology domain of its precursor protein p105.","date":"2013","source":"Pharmacognosy magazine","url":"https://pubmed.ncbi.nlm.nih.gov/23661994","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21182083","id":"PMC_21182083","title":"Cystatin cures visceral leishmaniasis by NF-κB-mediated proinflammatory response through co-ordination of TLR/MyD88 signaling with p105-Tpl2-ERK pathway.","date":"2010","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21182083","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26300007","id":"PMC_26300007","title":"NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function.","date":"2015","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/26300007","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23175812","id":"PMC_23175812","title":"An early onset progressive motor neuron disorder in Scyl1-deficient mice is associated with mislocalization of TDP-43.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23175812","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7694229","id":"PMC_7694229","title":"Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhibition of NF-kappa B DNA binding activity.","date":"1993","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/7694229","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30876435","id":"PMC_30876435","title":"Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL).","date":"2019","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30876435","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10023675","id":"PMC_10023675","title":"Physical interaction of the bHLH LYL1 protein and NF-kappaB1 p105.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10023675","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23022054","id":"PMC_23022054","title":"Aj-rel and Aj-p105, two evolutionary conserved NF-κB homologues in sea cucumber (Apostichopus japonicus) and their involvement in LPS induced immunity.","date":"2012","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23022054","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2377285","id":"PMC_2377285","title":"Multiparameter flow cytometric analysis of neoplasms of the central nervous system: correlation of nuclear antigen p105 and DNA content with clinical behavior.","date":"1990","source":"Neurosurgery","url":"https://pubmed.ncbi.nlm.nih.gov/2377285","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19664134","id":"PMC_19664134","title":"Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.","date":"2009","source":"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/19664134","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8246448","id":"PMC_8246448","title":"Immunoreactivity of the nuclear antigen p105 is associated with plaques and tangles in Alzheimer's disease.","date":"1993","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/8246448","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17082652","id":"PMC_17082652","title":"Inhibition of Helicobacter hepaticus-induced colitis by IL-10 requires the p50/p105 subunit of NF-kappa B.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17082652","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16394015","id":"PMC_16394015","title":"Defective activation of ERK in macrophages lacking the p50/p105 subunit of NF-kappaB is responsible for elevated expression of IL-12 p40 observed after challenge with Helicobacter hepaticus.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16394015","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1913456","id":"PMC_1913456","title":"Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in advanced gastric cancers.","date":"1991","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/1913456","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25917973","id":"PMC_25917973","title":"MiR-31 modulates coelomocytes ROS production via targeting p105 in Vibrio splendidus challenged sea cucumber Apostichopus japonicus in vitro and in vivo.","date":"2015","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25917973","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20505071","id":"PMC_20505071","title":"Scyl1 facilitates nuclear tRNA export in mammalian cells by acting at the nuclear pore complex.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/20505071","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16292892","id":"PMC_16292892","title":"The comet assay to determine the mode of cell death for the ultrasonic delivery of doxorubicin to human leukemia (HL-60 Cells) from Pluronic P105 micelles.","date":"2005","source":"Technology in cancer research & treatment","url":"https://pubmed.ncbi.nlm.nih.gov/16292892","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29084252","id":"PMC_29084252","title":"Regulation of NF-κB by the p105-ABIN2-TPL2 complex and RelAp43 during rabies virus infection.","date":"2017","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/29084252","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8398903","id":"PMC_8398903","title":"The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.","date":"1993","source":"Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/8398903","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19695220","id":"PMC_19695220","title":"ABIN-1 negatively regulates NF-kappaB by inhibiting processing of the p105 precursor.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19695220","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8649779","id":"PMC_8649779","title":"Inhibition of p105 processing by NF-kappaB proteins in transiently transfected cells.","date":"1996","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8649779","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8900374","id":"PMC_8900374","title":"Elevated serum levels of p105(erbB-2) in patients with advanced-stage prostatic adenocarcinoma.","date":"1996","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/8900374","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34721373","id":"PMC_34721373","title":"Defining the Role of Nuclear Factor (NF)-κB p105 Subunit in Human Macrophage by Transcriptomic Analysis of NFKB1 Knockout THP1 Cells.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34721373","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20204281","id":"PMC_20204281","title":"The expression of NAD(P)H:quinone oxidoreductase 1 is increased along with NF-kappaB p105/p50 in human cutaneous melanomas.","date":"2010","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/20204281","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25225457","id":"PMC_25225457","title":"IKK-induced NF-κB1 p105 proteolysis is critical for B cell antibody responses to T cell-dependent antigen.","date":"2014","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25225457","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16448710","id":"PMC_16448710","title":"Phosphorylation of NF-kappaB1/p105 by oncoprotein kinase Tpl2: implications for a novel mechanism of Tpl2 regulation.","date":"2006","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/16448710","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27239439","id":"PMC_27239439","title":"miRNA expression profiling of Epstein-Barr virus-associated NKTL cell lines by Illumina deep sequencing.","date":"2016","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/27239439","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17081983","id":"PMC_17081983","title":"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17081983","citation_count":2861,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22504420","id":"PMC_22504420","title":"Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22504420","citation_count":958,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16713569","id":"PMC_16713569","title":"A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16713569","citation_count":610,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26638075","id":"PMC_26638075","title":"A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26638075","citation_count":433,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26871637","id":"PMC_26871637","title":"Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing.","date":"2016","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26871637","citation_count":423,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889548","id":"PMC_8889548","title":"Normalization and subtraction: two approaches to facilitate gene discovery.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889548","citation_count":401,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31006538","id":"PMC_31006538","title":"Intrinsically Disordered Protein TEX264 Mediates ER-phagy.","date":"2019","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/31006538","citation_count":296,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22863883","id":"PMC_22863883","title":"A high-throughput approach for measuring temporal changes in the interactome.","date":"2012","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/22863883","citation_count":273,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11042159","id":"PMC_11042159","title":"Normalization and subtraction of cap-trapper-selected cDNAs to prepare full-length cDNA libraries for rapid discovery of new genes.","date":"2000","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11042159","citation_count":226,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30033366","id":"PMC_30033366","title":"Mapping the Genetic Landscape of Human Cells.","date":"2018","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/30033366","citation_count":225,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27173435","id":"PMC_27173435","title":"An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27173435","citation_count":211,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21988832","id":"PMC_21988832","title":"Toward an understanding of the protein interaction network of the human liver.","date":"2011","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/21988832","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16903783","id":"PMC_16903783","title":"Role of the AP2 beta-appendage hub in recruiting partners for clathrin-coated vesicle assembly.","date":"2006","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/16903783","citation_count":203,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22623531","id":"PMC_22623531","title":"Functional genomics identifies therapeutic targets for MYC-driven cancer.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22623531","citation_count":203,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26673895","id":"PMC_26673895","title":"A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.","date":"2015","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26673895","citation_count":198,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20548946","id":"PMC_20548946","title":"A genome-wide association study of optic disc parameters.","date":"2010","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20548946","citation_count":170,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25468996","id":"PMC_25468996","title":"E-cadherin interactome complexity and robustness resolved by quantitative proteomics.","date":"2014","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/25468996","citation_count":162,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32877691","id":"PMC_32877691","title":"A High-Density Human Mitochondrial Proximity Interaction Network.","date":"2020","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32877691","citation_count":148,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31871319","id":"PMC_31871319","title":"Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31871319","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49450,"output_tokens":2003,"usd":0.089197},"stage2":{"model":"claude-opus-4-6","input_tokens":5093,"output_tokens":1885,"usd":0.108885},"total_usd":0.42779,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":61303,"output_tokens":2588,"usd":0.111365},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":5529,"output_tokens":2050,"usd":0.118343}},"stage1_raw":"Looking through the abstracts, I need to identify papers specifically about SCYL1 (Scy1-like 1, also known as N-terminal kinase-like protein). The vast majority of papers in this corpus are about NF-κB p105/p50 (NFKB1), retinoblastoma p105-RB, or Pluronic P105 - none of which are SCYL1. I need to identify only the papers genuinely about the SCYL1 gene/protein.\n\nRelevant SCYL1 papers: PMIDs 18556652, 17571074, 20209057, 24481816, 23175812, 20505071.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"Loss-of-function mutation in Scyl1 causes the murine neurodegenerative disease mdf (muscle deficient), characterized by cerebellar atrophy, Purkinje cell loss, and optic nerve atrophy. SCYL1 is an evolutionarily conserved putative component of the nucleocytoplasmic transport machinery, prominently expressed in neurons and enriched at CNS synapses and neuromuscular junctions.\",\n      \"method\": \"Positional cloning of mdf mouse mutant; histopathological analysis; expression profiling by immunohistochemistry and Western blot\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with defined neuropathological phenotype, single study\",\n      \"pmids\": [\"17571074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"SCYL1 binds components of COPI coats (co-immunoprecipitates with βCOP from brain lysates) using a C-terminal RKLD-COO⁻ sequence analogous to the KKXX-COO⁻ COPI-binding motif of transmembrane ER proteins. SCYL1 localizes to the ERGIC and cis-Golgi in an Arf1-independent manner, and siRNA-mediated knockdown disrupts COPI-mediated retrograde trafficking of the KDEL receptor to the ER without affecting anterograde traffic.\",\n      \"method\": \"Mass spectrometry interactome screen; pull-down assays; co-immunoprecipitation; siRNA knockdown; live-cell fluorescence microscopy; KDEL receptor retrograde trafficking assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (MS, Co-IP, pulldown, localization, functional KD assay) in a single rigorous study\",\n      \"pmids\": [\"18556652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SCYL1 knockdown causes enlargement of Golgi surface area and volume, and disrupts orderly Golgi ultrastructure (increased cisternal luminal width), without altering Golgi polarity or cisternae number. SCYL1 localizes to the Golgi in a manner dependent on the golgin p115, and interacts with the cis-Golgi-associated protein 58K/FTCD, placing SCYL1 at an interface between the golgin network and COPI trafficking.\",\n      \"method\": \"siRNA knockdown; confocal and electron microscopy morphometry; co-immunoprecipitation with FTCD; p115 knockdown epistasis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — clean KD with defined morphological phenotype and binding partner identification, single lab\",\n      \"pmids\": [\"20209057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SCYL1 functions as a cytoplasmic component of the nuclear tRNA export machinery. It binds tRNA saturably, associates with the nuclear pore complex by interacting with Nup98, co-purifies with exportin-t, exportin-5, RanGTPase, and eEF-1A, and forms a quaternary complex with exportin-t, tRNA, and RanGTP in vitro. SCYL1 interacts directly with exportin-t and RanGTP but not RanGDP, and overexpression restores export of a nuclear export-defective tRNA mutant.\",\n      \"method\": \"In vitro binding assays; co-purification/co-immunoprecipitation; in vitro reconstitution of quaternary complex; functional complementation assay in COS-7 cells; Nup98 interaction assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro reconstitution of complex, direct binding assays, and functional rescue, multiple orthogonal methods in single study\",\n      \"pmids\": [\"20505071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Neural-specific deletion of Scyl1 causes early-onset progressive motor neuron disease with features of ALS, including loss of lower motor neurons, axonal degeneration, and neuroinflammation. Loss of SCYL1 leads to mislocalization and cytoplasmic accumulation of TDP-43 and ubiquilin-2 in lower motor neurons. Skeletal muscle-specific deletion does not cause motor dysfunction, establishing a cell-autonomous neural requirement for SCYL1 in motor neuron survival.\",\n      \"method\": \"Conditional (neural- and muscle-specific) Scyl1 knockout mice; histopathology; immunofluorescence for TDP-43 and ubiquilin-2; electrophysiology; behavioral testing\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with cell-type specificity established, multiple orthogonal readouts including TDP-43 mislocalization as molecular mechanism\",\n      \"pmids\": [\"23175812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SCYL1 oligomerizes through centrally located HEAT repeats and uses its C-terminal RKXX-COO⁻ motif to interact directly with the appendage domain of the coatomer subunit γ2-COP (COPG2). Through a distinct binding site, SCYL1 selectively interacts with class II Arfs (notably Arf4), thereby scaffolding class II Arfs to γ2-bearing COPI subcomplexes. Disruption of this scaffolding function causes tubulation of the ERGIC and cis-Golgi.\",\n      \"method\": \"Pull-down assays; co-immunoprecipitation; in vitro direct binding with purified proteins; domain mapping/mutagenesis; dominant-negative and siRNA approaches; fluorescence microscopy\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct binding with purified proteins, domain mutagenesis, and functional consequence of disruption, multiple orthogonal methods\",\n      \"pmids\": [\"24481816\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SCYL1 is a catalytically inactive pseudokinase that functions as an accessory factor in COPI-mediated retrograde trafficking by scaffolding class II Arfs (via Arf4) to γ2-COP-containing COPI subcomplexes through its C-terminal RKXX-COO⁻ motif and HEAT repeat oligomerization domain; it also participates in nuclear tRNA export by forming a complex with exportin-t, RanGTP, and Nup98 at the nuclear pore, and its loss causes TDP-43 mislocalization and progressive motor neuron degeneration in mice.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nLooking at the corpus, I need to classify papers as KEEP (about SCYL1) or EXCLUDE (about other genes/proteins with \"p105\" or other names that collide).\n\n**Classification:**\n- Papers [1]-[27] in the main corpus (except [36], [47], [53], [70], [77], [89]): These are overwhelmingly about NF-κB p105/p50 (NFKB1), retinoblastoma p105-Rb, erbB-2 p105, or Pluronic P105 polymer — EXCLUDE (alias collisions)\n- Paper [36]: Scyl1 regulates COPI-mediated retrograde traffic — KEEP\n- Paper [47]: Mutation in Scyl1 gene causes spinocerebellar neurodegeneration — KEEP\n- Paper [53]: Scyl1 regulates Golgi morphology — KEEP\n- Paper [70]: Scyl1 scaffolds class II Arfs to COPI subcomplexes — KEEP\n- Paper [77]: Scyl1-deficient mice, TDP-43 mislocalization — KEEP\n- Paper [89]: Scyl1 facilitates nuclear tRNA export — KEEP\n- Papers [28], [65], [69], [90]: Pluronic P105 polymer — EXCLUDE\n- Papers [35], [60], [66], [82], [84], [87]: p105 nuclear antigen (proliferation marker, different protein) — EXCLUDE\n- Paper [41]: miR-335 targets Rb1/p105 — EXCLUDE\n- Paper [56]: p105-RB — EXCLUDE\n- Paper [71]: p105-Rb — EXCLUDE\n- Paper [95]: p105erbB-2 — EXCLUDE\n\n**Additional curated papers:**\n- [1] Phosphoproteomics (PMID:17081983): global phospho, mentions SCYL1 incidentally — not mechanistic for SCYL1, EXCLUDE\n- [3],[4],[7],[8]: Interactome maps listing SCYL1 as a detected protein — no mechanistic detail, EXCLUDE\n- [10]: Ataxia protein interaction network — mentions SCYL1 context — EXCLUDE (no mechanism)\n- Others: large-scale proteomics/genomics without SCYL1-specific mechanism — EXCLUDE\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"Loss-of-function mutation in Scyl1, encoding an evolutionarily conserved N-terminal kinase-like (pseudokinase) protein, was identified as the cause of the autosomal recessive murine neurodegenerative disease 'muscle deficient' (mdf), characterized by cerebellar atrophy, Purkinje cell loss, and optic nerve atrophy. Scyl1 was found to be prominently expressed in neurons and enriched at CNS synapses and neuromuscular junctions.\",\n      \"method\": \"Positional cloning and loss-of-function mutation mapping in mdf mice; immunohistochemistry and expression analysis\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct genetic identification of causative mutation with histopathological phenotypic readout, replicated across independent analyses\",\n      \"pmids\": [\"17571074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"SCYL1 (Scy1-like 1) was identified as a binding partner of COPI coat components (coatomer). SCYL1 uses a C-terminal RKLD-COO⁻ sequence (analogous to the KKXX-COO⁻ motif of transmembrane ER-resident proteins) to bind COPI coats. SCYL1 co-localizes with βCOP at the ER-Golgi intermediate compartment (ERGIC) and cis-Golgi in an Arf1-independent manner, and siRNA-mediated knockdown of SCYL1 disrupts COPI-mediated retrograde trafficking of the KDEL receptor to the ER without affecting anterograde traffic.\",\n      \"method\": \"Mass spectrometry-based binding partner screen, pull-down assays, co-immunoprecipitation from brain lysates, siRNA knockdown with KDEL receptor trafficking assay, immunofluorescence co-localization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (MS screen, co-IP, siRNA functional assay) in a single study establishing COPI interaction and functional role\",\n      \"pmids\": [\"18556652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SCYL1 knockdown causes an increase in Golgi surface area and volume and disorganization of Golgi ultrastructure (increased cisternal luminal width), without disrupting Golgi polarity or cisternal number. SCYL1 localizes to the Golgi in a manner dependent on the golgin p115 network, and SCYL1 interacts with the cis-Golgi-associated protein 58K/FTCD (formiminotransferase cyclodeaminase), placing SCYL1 at the interface of the golgin network and COPI trafficking.\",\n      \"method\": \"siRNA knockdown with 3D confocal imaging and electron microscopy of Golgi morphology; co-immunoprecipitation of SCYL1 with 58K/FTCD; immunofluorescence after p115 knockdown\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — functional knockdown phenotype with EM and co-IP validation, single lab study\",\n      \"pmids\": [\"20209057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SCYL1 functions as a cytoplasmic component of the mammalian nuclear tRNA export machinery. SCYL1 binds tRNA saturably, associates with the nuclear pore complex via interaction with Nup98, and co-purifies with exportin-t, exportin-5, RanGTPase, and eEF-1A. SCYL1 interacts directly with exportin-t and RanGTP (but not RanGDP) in vitro, and exportin-t/tRNA/SCYL1/RanGTP form a quaternary complex in vitro. Overexpression of SCYL1 rescues export of a nuclear export-defective tRNA mutant in COS-7 cells.\",\n      \"method\": \"In vitro tRNA binding assay, co-purification/co-immunoprecipitation with nuclear pore and export machinery components, in vitro reconstitution of quaternary complex, functional rescue assay in COS-7 cells\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro reconstitution plus cellular functional assay, single lab study\",\n      \"pmids\": [\"20505071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Neural-specific deletion of Scyl1 is sufficient to cause progressive lower motor neuron (LMN) degeneration and motor dysfunction in mice, demonstrating that SCYL1 acts in a cell-autonomous manner in neurons. Loss of Scyl1 results in mislocalization and accumulation of TDP-43 and ubiquilin 2 into cytoplasmic inclusions within LMNs—a pathological hallmark of ALS. Skeletal muscle-specific deletion does not cause motor dysfunction, confirming the neural cell-autonomous requirement.\",\n      \"method\": \"Conditional (neural-specific and muscle-specific) Scyl1 knockout mice; immunofluorescence and immunohistochemistry for TDP-43 and ubiquilin 2 localization; neuropathological analysis of motor neurons and peripheral nerves\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific conditional knockouts with defined molecular (TDP-43 mislocalization) and cellular (LMN degeneration) phenotypic readouts\",\n      \"pmids\": [\"23175812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SCYL1 oligomerizes through centrally located HEAT repeats and uses its C-terminal RKXX-COO⁻ motif to interact directly with the appendage domain of coatomer subunit γ-2 (γ2-COP/COPG2). Through a distinct binding site, SCYL1 selectively interacts with class II Arfs (notably Arf4), thereby functioning as a scaffold that links class II Arfs specifically to γ2-COP-containing COPI subcomplexes. Disruption of this scaffolding causes tubulation of the ERGIC and cis-Golgi, similar to loss of Arf or Arf-GEF function.\",\n      \"method\": \"Pull-down assays mapping direct interaction with γ2-COP appendage domain; identification of Arf4-selective binding; dominant-negative and knockdown approaches with Golgi morphology readout (confocal and electron microscopy)\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct binding mapped to specific domains, orthogonal genetic and cell biological validation, mechanistic specificity established for Arf class and COP subcomplex\",\n      \"pmids\": [\"24481816\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SCYL1 is a catalytically inactive pseudokinase that functions as an accessory scaffold in COPI-mediated retrograde membrane trafficking by binding COPI coats via its C-terminal RKXX-COO⁻ motif and linking class II Arfs (Arf4) to γ2-COP-containing COPI subcomplexes through its HEAT repeat oligomerization domain; it also participates in nuclear tRNA export by forming a complex with exportin-t and RanGTP at the nuclear pore, and its loss in neurons causes TDP-43 mislocalization, lower motor neuron degeneration, and cerebellar atrophy.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SCYL1 is a catalytically inactive pseudokinase that scaffolds COPI-mediated retrograde vesicular trafficking at the ERGIC and cis-Golgi and participates in nuclear tRNA export. SCYL1 oligomerizes via central HEAT repeats and uses its C-terminal RKXX-COO⁻ motif to bind the γ2-COP appendage domain, while simultaneously recruiting class II Arfs (particularly Arf4) through a distinct site, thereby linking Arf regulation to γ2-COP-containing COPI subcomplexes; disruption of this scaffolding causes ERGIC/cis-Golgi tubulation and impaired KDEL receptor retrograde trafficking [PMID:18556652, PMID:24481816]. SCYL1 also forms a quaternary complex with exportin-t, tRNA, and RanGTP at the nuclear pore via direct interaction with Nup98, and its overexpression rescues export of a nuclear export-defective tRNA mutant [PMID:20505071]. Loss-of-function mutations in Scyl1 cause a progressive motor neuron disease in mice characterized by TDP-43 and ubiquilin-2 cytoplasmic mislocalization in lower motor neurons, with a cell-autonomous neural requirement for motor neuron survival [PMID:23175812, PMID:17571074].\",\n  \"teleology\": [\n    {\n      \"year\": 2007,\n      \"claim\": \"Positional cloning of the mdf mouse mutant identified SCYL1 as a neuronally expressed gene whose loss causes cerebellar and motor neuron degeneration, establishing it as essential for neuronal maintenance but leaving its molecular function unknown.\",\n      \"evidence\": \"Positional cloning of mdf locus; histopathology and expression profiling in mouse CNS\",\n      \"pmids\": [\"17571074\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single study without independent replication at that time\", \"Molecular mechanism of neurodegeneration not determined\", \"Relationship to intracellular trafficking not yet established\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of SCYL1 as a COPI coat-associated protein at the ERGIC/cis-Golgi that uses a C-terminal RKLD-COO⁻ motif to bind βCOP and is required for retrograde KDEL receptor trafficking resolved its primary molecular function as a COPI trafficking accessory factor.\",\n      \"evidence\": \"Mass spectrometry interactome; Co-IP from brain lysates; siRNA knockdown with KDEL receptor retrograde trafficking assay in cultured cells\",\n      \"pmids\": [\"18556652\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific coatomer subunit and Arf selectivity not yet defined\", \"How COPI trafficking function relates to neurodegeneration unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Two parallel studies revealed that SCYL1 loss disrupts Golgi morphology and that SCYL1 participates in nuclear tRNA export by forming a quaternary complex with exportin-t, tRNA, and RanGTP at the nuclear pore, uncovering a dual function in trafficking and RNA export.\",\n      \"evidence\": \"siRNA knockdown with EM morphometry and golgin p115 epistasis (Golgi role); in vitro reconstitution of quaternary complex, Nup98 binding, and functional rescue of export-defective tRNA (tRNA export role)\",\n      \"pmids\": [\"20209057\", \"20505071\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether COPI trafficking and tRNA export functions are mechanistically linked or independent remains unresolved\", \"Structural basis of the exportin-t/SCYL1/RanGTP complex not determined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Conditional knockout revealed a cell-autonomous neural requirement for SCYL1 in motor neuron survival and showed that SCYL1 loss causes cytoplasmic mislocalization of TDP-43 and ubiquilin-2, providing a molecular link between SCYL1 deficiency and ALS-like proteinopathy.\",\n      \"evidence\": \"Neural-specific vs. muscle-specific Scyl1 conditional knockout mice; TDP-43 and ubiquilin-2 immunofluorescence; behavioral and electrophysiological phenotyping\",\n      \"pmids\": [\"23175812\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TDP-43 mislocalization is a direct consequence of impaired tRNA export, COPI trafficking, or another pathway is unknown\", \"No patient cohort with SCYL1 mutations identified at this time\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Biochemical dissection showed SCYL1 oligomerizes via HEAT repeats and acts as a scaffold bridging class II Arfs (Arf4) to γ2-COP-containing COPI subcomplexes through separable binding sites, defining the precise molecular architecture of its COPI trafficking function.\",\n      \"evidence\": \"Purified-protein direct binding assays; domain mapping and mutagenesis; dominant-negative and siRNA approaches with fluorescence microscopy in cultured cells\",\n      \"pmids\": [\"24481816\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model of the SCYL1–γ2-COP–Arf4 ternary complex\", \"Whether class II Arf selectivity explains tissue-specific vulnerability of motor neurons is untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how SCYL1's dual roles in COPI retrograde trafficking and tRNA export converge to protect motor neurons, whether TDP-43 mislocalization is a proximal or downstream consequence of SCYL1 loss, and whether human SCYL1 mutations cause a comparable neurodegenerative disease.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Causal relationship between SCYL1 trafficking defects and TDP-43 proteinopathy not established\", \"No high-resolution structure of SCYL1 in any complex\", \"No human disease cohort linked to SCYL1 mutations in the timeline\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [1, 2, 5]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005635\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [1, 2, 5]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"complexes\": [\n      \"COPI coat (γ2-COP subcomplex)\"\n    ],\n    \"partners\": [\n      \"COPG2\",\n      \"ARF4\",\n      \"XPOT\",\n      \"NUP98\",\n      \"FTCD\",\n      \"ARCN1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"SCYL1 is a catalytically inactive pseudokinase that functions as a scaffolding adaptor in COPI-mediated retrograde membrane trafficking and in nuclear tRNA export. It oligomerizes via central HEAT repeats and uses a C-terminal RKXX-COO⁻ motif to bind the γ2-COP appendage domain, selectively linking class II Arfs (Arf4) to γ2-COP-containing COPI subcomplexes at the ERGIC and cis-Golgi; its loss disrupts COPI-dependent KDEL receptor recycling and causes Golgi disorganization [PMID:18556652, PMID:24481816, PMID:20209057]. SCYL1 also participates in nuclear tRNA export by forming a quaternary complex with exportin-t, tRNA, and RanGTP at the nuclear pore [PMID:20505071]. Neural-specific loss of Scyl1 in mice causes progressive lower motor neuron degeneration with cytoplasmic TDP-43 and ubiquilin 2 accumulation, cerebellar Purkinje cell loss, and optic nerve atrophy, establishing a cell-autonomous neuronal requirement [PMID:17571074, PMID:23175812].\",\n  \"teleology\": [\n    {\n      \"year\": 2007,\n      \"claim\": \"Positional cloning of the murine mdf locus identified Scyl1 as a neuronally-expressed pseudokinase whose loss causes cerebellar atrophy and Purkinje cell degeneration, establishing it as essential for neuronal survival but leaving its molecular function unknown.\",\n      \"evidence\": \"Positional cloning and loss-of-function mutation mapping in mdf mice with immunohistochemistry\",\n      \"pmids\": [\"17571074\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular mechanism by which SCYL1 supports neuronal viability was unknown\",\n        \"Whether SCYL1 functions cell-autonomously in neurons was untested\",\n        \"No binding partners or pathway placement identified\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Discovery that SCYL1 directly binds COPI coat components via a C-terminal RKLD-COO⁻ motif and is required for retrograde KDEL receptor trafficking placed this pseudokinase in the COPI-dependent ER-Golgi recycling pathway.\",\n      \"evidence\": \"Mass spectrometry screen, co-IP from brain lysates, siRNA knockdown with KDEL receptor trafficking assay\",\n      \"pmids\": [\"18556652\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Which specific COPI subunit(s) SCYL1 engages was not resolved\",\n        \"Whether SCYL1 links COPI to specific Arf GTPases was unknown\",\n        \"Connection between COPI trafficking role and neurodegeneration not established\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Two parallel studies expanded SCYL1's functional repertoire: one showed SCYL1 depletion disrupts Golgi architecture and placed it at the golgin p115/58K network interface, while another demonstrated SCYL1 forms a quaternary complex with exportin-t, tRNA, and RanGTP, implicating it in nuclear tRNA export.\",\n      \"evidence\": \"siRNA knockdown with 3D confocal and EM for Golgi morphology; in vitro reconstitution of exportin-t/tRNA/SCYL1/RanGTP complex and tRNA export rescue in COS-7 cells\",\n      \"pmids\": [\"20209057\", \"20505071\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Relative physiological importance of tRNA export versus COPI trafficking roles not resolved\",\n        \"Whether tRNA export function is relevant to the neurodegenerative phenotype is unknown\",\n        \"Golgi morphology study from a single lab without independent replication\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Neural-specific conditional knockout demonstrated SCYL1 acts cell-autonomously in neurons, and linked its loss to cytoplasmic TDP-43 and ubiquilin 2 accumulation in lower motor neurons — hallmarks of ALS pathology — bridging the trafficking role to a neurodegeneration-relevant mechanism.\",\n      \"evidence\": \"Conditional neural-specific and muscle-specific Scyl1 knockout mice with TDP-43 and ubiquilin 2 immunolocalization\",\n      \"pmids\": [\"23175812\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Causal chain from COPI trafficking defect to TDP-43 mislocalization not delineated\",\n        \"Whether SCYL1 loss causes TDP-43 aggregation through impaired autophagy, proteasome dysfunction, or another route is unresolved\",\n        \"No human genetic disease association demonstrated\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Biochemical mapping revealed SCYL1 oligomerizes through HEAT repeats and acts as a selective scaffold linking class II Arfs (Arf4) to γ2-COP-containing COPI subcomplexes via distinct binding sites, providing a structural explanation for its specificity in retrograde trafficking.\",\n      \"evidence\": \"Pull-down assays mapping γ2-COP appendage domain interaction; Arf4-selective binding; dominant-negative and knockdown with Golgi morphology readout\",\n      \"pmids\": [\"24481816\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structural model of the SCYL1–γ2-COP–Arf4 ternary complex\",\n        \"Whether additional cargo adaptors cooperate with SCYL1 at the ERGIC is unknown\",\n        \"Functional significance of SCYL1 pseudokinase domain remains uncharacterized\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The mechanistic link between SCYL1's COPI scaffolding and/or tRNA export roles and the downstream TDP-43 mislocalization causing motor neuron degeneration remains unresolved, as does the functional significance of the catalytically inactive kinase-like domain.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No causal pathway connecting COPI trafficking or tRNA export defects to TDP-43 proteinopathy\",\n        \"Pseudokinase domain function or potential non-canonical catalytic activity not addressed\",\n        \"Human genetic validation as a Mendelian disease gene for neurodegeneration not reported in this timeline\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [1, 2, 5]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [1, 2, 5]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"complexes\": [\n      \"COPI coat complex (accessory/scaffold)\",\n      \"exportin-t/RanGTP tRNA export complex\"\n    ],\n    \"partners\": [\n      \"COPG2\",\n      \"ARF4\",\n      \"XPOT\",\n      \"RAN\",\n      \"FTCD\",\n      \"NUP98\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}